Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Research Partnership With Humana Could Inform Drug Development Decisions

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer and Humana announce five-year partnership to explore ways to improve the quality, outcomes and cost of health care for seniors using medical claims data from Humana's research affiliate, Competitive Health Analytics.

You may also be interested in...



Allergan-Humana Research To Explore Alzheimer’s, Glaucoma Treatment

Humana’s collaboration with Allergan follows earlier research agreements with Pfizer, Lilly, Astellas and others.

Lilly-Humana Outcomes Research Partnership Has Initial Focus on Diabetes

The research will cover the impact of interventions on outcomes, adherence programs, disease management and pharmacoeconomics.

Big Data Poised To Change Pharma R&D, McKinsey Suggests

A McKinsey & Company white paper highlights the potential for big data gathered from across the health care spectrum to revolutionize pharma R&D.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS072893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel